|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1301 I Street, NW |
Address2 | Suite 525 West |
City | Washington |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Woonsocket |
State | RI |
Zip Code | 02895 |
Country | USA |
|
5. Senate ID# 302778-1003157
|
||||||||
|
6. House ID# 394420000
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Russell C. Ring, Senior Vice President, Government Affairs |
Date | 01/21/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues pertaining to health information technology, generic drugs, comparative effectiveness, internet pharmacy, and changes to federal privacy laws.
HR 6353, Ryan Haight Online Pharmacy Consumer Protection Act of 2008
S 980, Online Pharmacy Consumer Protection Act of 2007
S 1814, Health Information Privacy and Security Act,
HR 5442, Technologies for Restoring Users Security & Trust Act of 2008
HR 6898, Health-e Information Technology Act of 2008
HR 6357, The PRO(TECH)T Act
S 1693, Health Information Privacy and Security Act
HR 5442, Technologies for Restoring Users Security and Trust in Health Information Act of 2008
HR1038, To amend the Public Health Service Act to provide for the licensing of comparable and interchangeable biological products, and for other purposes.
S 623, A bill to amend the Public Health Service Act to provide for the licensing of comparable and interchangeable biological products, and for other purposes.
HR 5629, Pathway for Biosimilars Act
S 3408, Comparative Effectiveness Research Act of 2008
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Federal Trade Commission (FTC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Russell |
Ring |
|
|
|
Wendy |
Sussman |
|
|
|
Michael |
Ayotte |
|
|
|
Tracy |
Baroni Allmon |
|
|
|
Christine |
Simmon |
|
|
|
Heather |
Cutler |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues related to pharmacy payments, the Medicare Part D and the competitive bidding program for diabetes.
S 1951, Fair Medicaid Drug Payment Act of 2007
HR 3700, Fair Medicaid Drug Payment Act of 2007
HR 3140, Saving Our Community Pharmacies Act of 2007
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Russell |
Ring |
|
|
|
Wendy |
Sussman |
|
|
|
Michael |
Ayotte |
|
|
|
Tracy |
Baroni Allmon |
|
|
|
Christine |
Simmon |
|
|
|
Heather |
Cutler |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Issues related to antitrust exemptions for certain healthcare professional and labor organizing.
HR 971, Community Pharmacy Fairness Act of 2007
S 885, Community Pharmacy Fairness Act of 2007
S 2161, Community Pharmacy Fairness Act of 2007
S 1041, Employee Free Choice Act of 2007
HR 800, Employee Free Choice Act of 2007
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Russell |
Ring |
|
|
|
Wendy |
Sussman |
|
|
|
Michael |
Ayotte |
|
|
|
Tracy |
Baroni Allmon |
|
|
|
Christine |
Simmon |
|
|
|
Heather |
Cutler |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Pharmacy Issues related to the sale of food and drugs, drug safety and drug abuse, repackaging of prescription drugs, medication guides and credit card fees for pharmacies.
HR 5839, To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs.
HR 3610, Food and Drug Import Safety Act of 2007
HR 4911, Human Growth Hormone Restriction Act of 2007
S 877, Controlling the Abuse of Prescriptions Act of 2007
S 654, Safe Food Act of 2007
HR 1148, Safe Food Act of 2007
HR 5904, Safe FEAST Act of 2008
HR 5546, Credit Card Fair Fee Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Russell |
Ring |
|
|
|
Wendy |
Sussman |
|
|
|
Michael |
Ayotte |
|
|
|
Tracy |
Baroni Allmon |
|
|
|
Christine |
Simmon |
|
|
|
Heather |
Cutler |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
Issues related to greater use of information technology and changes to federal privacy laws.
S 1814, Health Information Privacy and Security Act
HR 5442, Technologies for Restoring Users' Security & Trust Act of 2008
HR 6898, Health-e Information Technology Act of 2008
HR 6357, The PRO(TECH)T Act
S 1693 Health Information Privacy and Security Act
HR 5442 Technologies for Restoring Users Security and Trust in Health Information Act of 2008
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Russell |
Ring |
|
|
|
Wendy |
Sussman |
|
|
|
Michael |
Ayotte |
|
|
|
Tracy |
Baroni Allmon |
|
|
|
Christine |
Simmon |
|
|
|
Heather |
Cutler |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Issues related to tax credits for employers for workforce development.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Russell |
Ring |
|
|
|
Wendy |
Sussman |
|
|
|
Michael |
Ayottee |
|
|
|
Tracy |
Baroni Allmon |
|
|
|
Christine |
Simmon |
|
|
|
Heather |
Cutler |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |